5Zhou H, Cheng X, Jin H. Identification of amino acids that are critical to the processivity function of respiratory syncytial virus M2 - 1 protein [J] .JVirol, 2003, 77 (9): 5046-5053.
6Ghildyal R, Ho A, Jans DA. Central role of the respiratory syncytial virus matrix protein in infection [ J] . FEMS Microbiol Rev, 2006, 30 (5) : 692 - 705.
7Hall CB. Respiratory syncytial virus and parainfluenza virus [ J ] . N EnglJMed, 2001, 344 (25):1 917-1 928.
8Polack FP, Teng MN, Colins PL, et al. A role for immune complexes in enhanced respiratory syncytial virus disease [ J ] . J Exp Med, 2002, 196 (6): 859-865.
9Openshaw PJ, Tregoning JS. Immune responses and disease enhance- ment during respiratory syncytial virus infection [ J ] . Clin Microbiol Rev. 2005. 18 (3): 541-555.
10Legg JP, Hussain IR, Warner JA, et al. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis [ J] . Am J Respir Crit Care Med, 2003, 168 (6) : 633 -639.
2Fleming D M, Elliot A J. Respiratory syncytial virus: a sleeping giant? Eur Respir J, 2007, 30:1029-1031.
3Karron R A. Respiratory Syncytial Virus Vaccine. In: Plotkin S A, Orenstein W A, Offit P A, eds. Vaccines, 5th ed. Philadelphia: Saunders, Elsevier, 2008. 1283-1293.
4Power U F. Respiratory syncytial virus (RSV) vaccines-two steps back for one leap forward. J Clin Virol, 2008, 41:38-44.
5Englund J. In search of a vaccine for respiratory syncytial virus: the saga continues. J Infect Dis, 2005, 191:1036-1039.
6Zeng R, Qi X, Gong W, et al. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2. Vaccine, 2007, 25:7422-7428.
7Fu Y, He J, Zheng X, et al. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice. Biochem Biophys Res Commun, 2009, 381:528-532.
8Fu Y H, He J S, Wang X B, et al. A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus. Biochem Bioph Res Co, 2010, 395: 87-92.
9Xie C, He J S, Zhang M, et al. Oral respiratory syncytial virus (RSV) DNA vaccine expressing RSV F protein delivered by attenuated Salmonella typhimurium. Hum Gene Ther, 2007, 18:746-752.
10Ghildyal R, Ho A, Jarls D A. Central role of the respiratory syncytial virus matrix protein in infection. FEMS Microbiol Rev, 2006, 30" 692-705.
